Learning Objectives
Menopause 101 Course: Menopause 101: Guidelines for Clinical Practice
By participating in this activity, attendees should be able to
- Understand the pathophysiology of menopause
- Assess various treatment options, including hormone therapy and alternatives
- Become familiar with other issues affecting midlife women including weight gain, sexual function, mood, sleep, and bone and cardiovascular health
Opening Symposium—Vasomotor Symptoms: What’s New, What Works and Main Program—Menopause Science and Care: An Inclusive Perspective
By participating in this activity, attendees should be able to
- Recognize issues in clinical practice for women at all stages of the menopause spectrum—perimenopause, menopause, and postmenopause
- Explore what’s new and what works for treating vasomotor symptoms and implications for mental and physical health
- Discuss cardiovascular disease at midlife and the effect of estrogen over the lifespan
- Understand the NAMS Hormone Therapy Position Statement and how to translate these guidelines to practice
- Appreciate the use of psychedelics in the care of midlife women and prevalence and treatment options for posttraumatic stress disorder
- Evaluate the controversies in genitourinary syndrome of menopause including the use of lasers and probiotics and the vaginal microbiome
- Assess survivorship care in breast cancer and the role of diet in prevention
- Discuss the behavioral and pharmacologic treatment options for sleep disorders and implications of sleep loss on health
- Evaluate bone health and review prevention and treatment options for osteoporosis
- Become familiar with disparities in women’s cardiovascular health and the menopause transition
- Understand the pharmacologic and behavioral treatment options for weight and obesity
- Recognize the barriers women face in academic medicine
- Manage sexual health issues in midlife women including mindfulness for the management of low libido
Continuing Medical Education Credits and Pharmacotherapeutic Hours
Please note that continuing education credits may be claimed for either the in-person Annual Meeting or the OnDemand virtual offering. Credit cannot be claimed for both the live and the Internet enduring activities.
In-Person Meeting—October 12-15, 2022—Atlanta, Georgia
Menopause 101 Course: Menopause 101: Guidelines for Clinical Practice
NAMS designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other healthcare professionals who participate in this activity will receive a certificate of participation. A maximum of 2.0 pharmacotherapeutic hours are also available.
Opening Symposium—Vasomotor Symptoms: What’s New, What Works and Main Program—Menopause Science and Care: An Inclusive Perspective
NAMS designates this live activity for a maximum of 25.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other healthcare professionals who participate in this activity will receive a certificate of participation. A maximum of 9.25 pharmacotherapeutic hours are also available.
On-Demand Virtual Offering
Menopause 101 Course: Menopause 101: Guidelines for Clinical Practice
NAMS designates this Internet enduring activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other healthcare professionals who participate in this activity will receive a certificate of participation. A maximum of 2.0 pharmacotherapeutic hours are also available.
Opening Symposium—Vasomotor Symptoms: What’s New, What Works and Main Program—Menopause Science and Care: An Inclusive Perspective
NAMS designates this Internet enduring activity for a maximum of 21.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other healthcare professionals who participate in this activity will receive a certificate of participation. A maximum of 7.25 pharmacotherapeutic hours are also available.